TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
暂无分享,去创建一个
S. Srivastava | I. Sesterhenn | I. Sesterhenn | H. Li | J. S. Gutkind | V. Patel | Yongmei Chen | G. Petrovics | D. Mcleod | S. Shaheduzzaman | A. Dobi | Chen Sun | Hongzhen Li | Shyh-Han Tan | T. Sreenath | Y. Chen | B. Furusato | M. Nau | M. Vahey | D. Hawksworth | A. Mohamed | R. Thangapazham | C. Sun | S-H Tan | G. Vaidyanathan | E. Whitman | C. Sun | J. Gutkind | Ganesan Vaidyanathan | Eric J. Whitman | David G. Mcleod | Rajesh L. Thangapazham
[1] P. Nelson,et al. A causal role for ERG in neoplastic transformation of prostate epithelium , 2008, Proceedings of the National Academy of Sciences.
[2] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[3] S. Srivastava,et al. Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer , 2008, Modern Pathology.
[4] D. Turner,et al. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer , 2008, Expert review of anticancer therapy.
[5] M. Rubin,et al. TMPRSS2-ETS fusion prostate cancer: biological and clinical implications , 2007, Journal of Clinical Pathology.
[6] I. Mills,et al. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor , 2007, EMBO reports.
[7] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[8] V. Srikantan,et al. Silencing of lactotransferrin expression by methylation in prostate cancer progression , 2007, Cancer biology & therapy.
[9] J. Witte. Multiple prostate cancer risk variants on 8q24 , 2007, Nature Genetics.
[10] Jianfeng Xu,et al. Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.
[11] D. Yee,et al. Disrupting insulin-like growth factor signaling as a potential cancer therapy , 2007, Molecular Cancer Therapeutics.
[12] O. Kallioniemi,et al. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. , 2006, Cancer research.
[13] C. Bloomfield,et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2006, Oncogene.
[15] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[16] A. Seth,et al. ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.
[17] A. Seth. Transcription factors in cancer , 2005 .
[18] Thomas Werner,et al. The next generation of literature analysis: Integration of genomic analysis into text mining , 2005, Briefings Bioinform..
[19] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2005, Oncogene.
[20] Guido Marcucci,et al. Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics , 2005, Current opinion in hematology.
[21] I. Kola,et al. Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. , 2004, Gene.
[22] K. Pienta,et al. VCaP, a cell-based model system of human prostate cancer. , 2001, In vivo.
[23] T. Libermann,et al. PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.
[24] L. Hood,et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. , 1999, Cancer research.
[25] M. Groudine,et al. Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter , 1992, Molecular and cellular biology.